AI
Friday, December 08, 2023 1:39:04 AM
No problem.
I believe I mentioned Fluidigm in two instances. One instance was that Fluidigm was repeatedly mentioned in the Nature preprint. The other instance was that the two institutions which hold board seats at the company with Kelly Ganjei as CEO invested heavily in Fluidigm. But I don't know which instance you mean. But glad to know you find it interesting.
https://investors.standardbio.com/news-releases/news-release-details/fluidigm-announces-250-million-strategic-capital-infusion-casdin
I believe I mentioned Fluidigm in two instances. One instance was that Fluidigm was repeatedly mentioned in the Nature preprint. The other instance was that the two institutions which hold board seats at the company with Kelly Ganjei as CEO invested heavily in Fluidigm. But I don't know which instance you mean. But glad to know you find it interesting.
https://investors.standardbio.com/news-releases/news-release-details/fluidigm-announces-250-million-strategic-capital-infusion-casdin
